Linda van Weele, PhD, MSc, joined BODFI in 2023. She obtained her PhD in Cancer, Stem Cells, and Developmental Biology while conducting her graduate research in Dr. Michael Clarke’s lab at Stanford University. Her research identified mechanisms by which breast cancer cells develop resistance to treatment. While at Stanford, Dr. Weele volunteered as a business development consultant for pharmaceutical and biotech companies as part of Biotech Connection – Bay Area. She recently completed VC University’s course on Venture Finance. She holds a MSc in Cancer, Genomics, and Developmental Biology and a BSc in Biomedical Sciences and Governance from Utrecht University, The Netherlands.
